At clinical concentrations, ciprofloxacin did not inhibit mitochondrial DNA replication, oxidative phosphorylation, protein synthesis, or mitochondrial mass (transmembrane potential). No difference in supercoiled forms of DNA was observed. The tetracyclines and chloramphenicol inhibited protein synthesis at clinically achievable concentrations, while rifampin, fusidic acid, and clindamycin did not.
The effects of 4-quinolones on mammalian cells remain obscure. Calf thymus DNA polymerase a primase complex and topoisomerases I and II are inhibited by the drugs but not at clinically achievable concentrations (17, 21) . The 4-quinolones at therapeutic concentrations lead to an increase of thymidine incorporation in phytohemagglutininstimulated lymphocytes (11, 12) . Furthermore, the 4-quinolones inhibit cell cycle progression (13) , mitogen-induced mononuclear cell proliferation (15) , and immunoglobulin secretion (13) . The synthesis of interleukin-1 is inhibited at high concentrations (26) , while the production of interleukin-2 is up-regulated (23, 25, 27) at the mRNA level (25) . DNA strand break induction by ciprofloxacin has also been reported (3) .
Mitochondria resemble bacteria in numerous ways (20) , and the ancestry of the mitochondrial (mt) rRNA genes of all eucaryotes has been traced to the eubacteria (16) . Topoisomerases I and II have been discovered in mammalian mitochondria (4, 9), but an mt gyrase (a type II topoisomerase) has not been detected. In bacteria, the 4-quinolones inhibit the enzyme DNA gyrase (1, 35) through direct binding to the enzyme or through the formation of a drug-DNA complex (29, 30, 33 (5) found that the incorporation of nucleotides into mt DNA decreased when mitochondria were exposed to nalidixic acid (100 to 300 ,ug/ml) and novobiocin (50 to 500 ,ug/ml). However, in the same laboratory (14) , it was recently reported that these drugs, at the high concentrations used, had a "nonspecific toxic" effect by inhibiting oxidative phosphorylation. When we measured oxidative phosphorylation, it was not at all affected by ciprofloxacin at clinical concentrations, but at 100 ,ug/ml ciprofloxacin significantly inhibited the respiratory control index by 47% (P < 0.01) and 71% (P < 0.001) with pyruvate and L-glutamate, respectively, as substrates.
Ciprofloxacin 5 ,ug/ml (Table 2) . These results are consistent with studies in our and other laboratories demonstrating an immunosuppressive effect of doxycycline both in vitro and in animal experiments (2, 10) . These antibiotics act in mitochondria in a similar fashion as in bacteria (7, 18) . To study intracellular mitochondria, we performed staining with rhodamine 123, a positively charged fluorochrome. Rhodamine 123 stains mitochondria selectively, is dependent on the electrochemical potential across the mt inner membrane, and also reflects the mt mass. When fluorescence was subsequently measured, no difference between cells treated with ciprofloxacin (5 and 20 ,ug/ml) and control cells without antibiotics were detected when Raji cells were incubated with ciprofloxacin for 24 h. However, doxycycline inhibited the uptake of rhodamine 123 (Fig. 1) .
In conclusion, of many antibiotics tested, only chloramphenicol and the tetracyclines (particularly doxycycline) inhibited mitochondria at clinically achievable concentrations. However, the 4-quinolone ciprofloxacin had no apparent effect on mitochondria. Thus, an inhibited mt function is not likely to be accounted for by ciprofloxacin-altered lymphocyte functions (12, 13) .
